DCF — JUPITER MEDICAL CENTER
Enterprise Value: $-561.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-561.1M
Enterprise Value
$-177.2M
PV of Cash Flows
$-383.8M
PV of Terminal Value
$-618.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $343.2M | $-35.1M | -10.0% | $-49.6M | $-45.1M |
| Year 2 | $353.5M | $-32.6M | -9.0% | $-47.6M | $-39.3M |
| Year 3 | $364.1M | $-30.0M | -8.0% | $-45.4M | $-34.1M |
| Year 4 | $375.0M | $-29.0M | -8.0% | $-44.9M | $-30.6M |
| Year 5 | $386.3M | $-28.9M | -7.0% | $-45.2M | $-28.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-561.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$333.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10725858105582607
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5